| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
NNOX
Nano-X Imaging
|
Dec 04, 2025 | BUY |
Strong Buy
+473.8% avg upside
7 analysts
|
$7.00
319.11% Upside
|
-54.0% |
|
LUCD
Lucid Diagnostics
|
Nov 18, 2025 | BUY |
Strong Buy
+345.6% avg upside
8 analysts
|
$3.00
177.85% Upside
|
-2.4% |
|
ELUT
Elutia
|
Nov 07, 2025 | BUY |
Strong Buy
+664.1% avg upside
5 analysts
|
$2.00
88.66% Upside
|
+11.7% |
|
CERS
Cerus
|
Nov 07, 2025 | BUY |
Strong Buy
+99.1% avg upside
10 analysts
|
$4.00
48.05% Upside
|
+64.9% |
|
CVRX
CVRx
|
Nov 06, 2025 | BUY |
Strong Buy
+136.7% avg upside
9 analysts
|
$13.00
162.64% Upside
|
-39.2% |
|
NPCE
NeuroPace
|
Nov 05, 2025 | BUY |
Strong Buy
+12.2% avg upside
11 analysts
|
$16.00
2.37% Upside
|
+16.8% |
|
ORGO
Organogenesis Holdings
|
Sep 26, 2025 | BUY |
Strong Buy
+375.4% avg upside
8 analysts
|
$9.00
268.93% Upside
|
-39.8% |
|
RCEL
Avita Medical
|
Sep 22, 2025 | BUY |
Strong Buy
+154.7% avg upside
10 analysts
|
$11.00
174.23% Upside
|
-24.3% |
|
SMTI
Sanara MedTech
|
Sep 02, 2025 | BUY |
Strong Buy
+76.2% avg upside
5 analysts
|
$46.00
108.97% Upside
|
-38.6% |
|
AXGN
AxoGen
|
Aug 11, 2025 | BUY |
Strong Buy
-25.7% avg upside
21 analysts
|
$26.00
41.99% Downside
|
+218.1% |
|
LMAT
Lemaitre Vascular
|
Aug 11, 2025 | HOLD |
Strong Buy
+7.8% avg upside
15 analysts
|
$95.00
1.06% Upside
|
+0.1% |
|
SIBN
SI-Bone
|
Aug 11, 2025 | BUY |
Strong Buy
+60.4% avg upside
18 analysts
|
$25.00
57.79% Upside
|
-8.1% |
|
BVS
Bioventus
|
Aug 11, 2025 | BUY |
Strong Buy
+41.0% avg upside
8 analysts
|
$14.00
60.80% Upside
|
+24.6% |
|
NYXH
Nyxoah
|
Aug 11, 2025 | BUY |
Strong Buy
+851.6% avg upside
12 analysts
|
$14.00
775.08% Upside
|
-58.4% |
|
MDXG
MiMedx Group
|
Jul 31, 2025 | BUY |
Strong Buy
+184.1% avg upside
17 analysts
|
$12.00
226.90% Upside
|
-49.9% |
|
XGN
Exagen
|
Jul 29, 2025 | BUY |
Strong Buy
+159.4% avg upside
10 analysts
|
$10.00
120.23% Upside
|
-56.9% |
|
PRE
Prenetics Group
|
Jun 23, 2025 | BUY |
Buy
+17.7% avg upside
12 analysts
|
$14.00
31.77% Downside
|
+92.0% |
|
TLSI
TriSalus Life Sciences
|
Jun 09, 2025 | BUY |
Strong Buy
+126.7% avg upside
8 analysts
|
$9.00
120.61% Upside
|
-52.1% |
|
PACB
Pacific Biosciences
|
Mar 18, 2025 | BUY |
Buy
+213.7% avg upside
14 analysts
|
$2.50
78.51% Upside
|
+9.0% |
|
PAVM
PAVmed
|
Mar 10, 2025 | HOLD |
Strong Buy
+725.5% avg upside
5 analysts
|
$120.00
2225.53% Upside
|
-46.0% |
|
AVR
Anteris Technologies Global Corp.
|
Jan 07, 2025 | BUY |
Strong Buy
+49.3% avg upside
5 analysts
|
$9.00
8.03% Downside
|
-13.9% |
|
AWHL
Aspira Women's Health
|
Oct 15, 2024 | HOLD |
Strong Buy
+1002.0% avg upside
6 analysts
|
$3.00
512.16% Upside
|
-32.0% |
|
VNRX
VolitionRX
|
May 15, 2024 | BUY |
Strong Buy
+590.6% avg upside
11 analysts
|
$2.50
74.87% Upside
|
-43.0% |
|
QUCY
Quantum Cyber
|
Nov 21, 2023 | HOLD |
Buy
+127.3% avg upside
4 analysts
|
— | · |
|
OFIX
Orthofix Medical
|
Oct 11, 2022 | BUY |
Strong Buy
+207.1% avg upside
15 analysts
|
— | -24.4% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.